SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global single photon emission computed tomography market is estimated to be valued at USD 3.13 Bn in 2024 and is expected to reach USD 4.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

Single photon emission computed tomography (SPECT) is a nuclear medicine tomographic imaging technique that uses gamma rays. SPECT imaging provides 3D information by measuring gamma radiation from multiple angles around the patient. Radiotracer, labeled with gamma-emitting radionuclides, is injected into the body and concentrated in specific organs, bones or tissues. The data collected from multiple detectors is reconstructed by computer into 3D images showing the distribution of the radiotracer in different organs. Areas where the radiotracer accumulates can indicate abnormal tissue function. SPECT imaging helps physicians diagnose and evaluate various medical conditions like cancer, heart disease, neurological disorders, and others. Technological advancements in detector materials and imaging algorithms are improving image quality and diagnostic value of SPECT scans. Growing applications across multiple therapeutic areas is expected to drive the global single photon emission computed tomography market.

Market Dynamics:

Global single photon emission computed tomography market growth is primarily driven by rising geriatric population and prevalence of chronic diseases like cancer and cardiovascular disorders. SPECT scans are widely used for cancer staging, detecting recurrence and evaluating treatment response. According to data from WHO, cancer burden is projected to grow globally with over 27 million new cancer cases estimated in 2040. Heart diseases also pose a major healthcare challenge. Growing applications of SPECT imaging in neurology, infection imaging and other therapeutic areas are expected to offer new opportunities. However, high installation and maintenance costs of SPECT systems limit widespread adoption especially in price-sensitive developing countries. New product launches with advanced hardware and software are addressing these concerns. Ongoing research on novel radiotracers and targeted radiopharmaceuticals could enhance diagnostic specificity of SPECT scans.

 Key Features of the Study:

• This report provides an in-depth analysis of the global single photon emission computed tomography market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global single photon emission computed tomography market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• The key companies covered as a part of this study include GE Healthcare, Curium, Bracco Imaging, Bruker, MiE GmbH, Siemens Healthcare, Koninklijke Philips N.V., Medisco Ltd., Spectrum Dynamics Medical, NTP Radioisotopes SOC Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global single photon emission computed tomography market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single photon emission computed tomography market.

Detailed Segmentation:

• Type:
  • Portable SPECT System
  • Standalone SPECT System
  • Others
• Type of Radioisotopes:
  • Tc-99m
  • Ra-223
  • Ga-67
  • I-123
  • Th-201
  • Others
• Application:
  • Cardiology
  • Oncology
  • Neurology
  • Others
• End User:
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical centers
  • Others
• Region: 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • GE Healthcare
  • Curium
  • Bracco Imaging
  • Bruker
  • MiE GmbH
  • Siemens Healthcare
  • Koninklijke Philips N.V.
  • Medisco Ltd.
  • Spectrum Dynamics Medical
  • NTP Radioisotopes SOC Ltd